Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
55.92
-0.17 (-0.30%)
At close: Nov 21, 2024, 4:00 PM
56.01
+0.09 (0.16%)
After-hours: Nov 21, 2024, 6:33 PM EST
Corcept Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 628.56 | 482.38 | 401.86 | 365.98 | 353.87 | 306.49 | Upgrade
|
| Revenue Growth (YoY) | 39.67% | 20.04% | 9.80% | 3.42% | 15.46% | 21.99% | Upgrade
|
| Cost of Revenue | 9.8 | 6.48 | 5.39 | 5.28 | 5.58 | 5.5 | Upgrade
|
| Gross Profit | 618.75 | 475.89 | 396.47 | 360.7 | 348.29 | 300.98 | Upgrade
|
| Selling, General & Admin | 244.1 | 184.26 | 152.85 | 122.36 | 105.33 | 100.36 | Upgrade
|
| Research & Development | 231.29 | 184.35 | 130.99 | 113.86 | 114.76 | 89.02 | Upgrade
|
| Operating Expenses | 475.39 | 368.61 | 283.84 | 236.22 | 220.09 | 189.38 | Upgrade
|
| Operating Income | 143.36 | 107.28 | 112.63 | 124.48 | 128.2 | 111.61 | Upgrade
|
| Interest & Investment Income | 22.98 | 17.28 | 3.56 | 0.53 | 3.4 | 5.07 | Upgrade
|
| Legal Settlements | - | - | -14 | - | - | - | Upgrade
|
| Pretax Income | 166.34 | 124.56 | 116.19 | 125.01 | 131.6 | 116.68 | Upgrade
|
| Income Tax Expense | 24.52 | 18.42 | 14.77 | 12.49 | 25.59 | 22.5 | Upgrade
|
| Net Income | 141.82 | 106.14 | 101.42 | 112.51 | 106.01 | 94.18 | Upgrade
|
| Preferred Dividends & Other Adjustments | 1.33 | 0.64 | 0.13 | - | - | - | Upgrade
|
| Net Income to Common | 140.49 | 105.5 | 101.29 | 112.51 | 106.01 | 94.18 | Upgrade
|
| Net Income Growth | 55.19% | 4.66% | -9.86% | 6.13% | 12.56% | 24.89% | Upgrade
|
| Shares Outstanding (Basic) | 103 | 104 | 107 | 116 | 115 | 114 | Upgrade
|
| Shares Outstanding (Diluted) | 111 | 112 | 116 | 126 | 124 | 123 | Upgrade
|
| Shares Change (YoY) | -1.56% | -3.64% | -7.94% | 1.42% | 1.33% | -3.25% | Upgrade
|
| EPS (Basic) | 1.36 | 1.02 | 0.95 | 0.97 | 0.92 | 0.82 | Upgrade
|
| EPS (Diluted) | 1.26 | 0.94 | 0.87 | 0.89 | 0.85 | 0.77 | Upgrade
|
| EPS Growth | 57.97% | 8.05% | -2.25% | 4.71% | 10.39% | 28.33% | Upgrade
|
| Free Cash Flow | 142.6 | 126.9 | 119.91 | 167.42 | 150.73 | 135.03 | Upgrade
|
| Free Cash Flow Per Share | 1.28 | 1.14 | 1.03 | 1.33 | 1.21 | 1.10 | Upgrade
|
| Gross Margin | 98.44% | 98.66% | 98.66% | 98.56% | 98.42% | 98.20% | Upgrade
|
| Operating Margin | 22.81% | 22.24% | 28.03% | 34.01% | 36.23% | 36.41% | Upgrade
|
| Profit Margin | 22.35% | 21.87% | 25.20% | 30.74% | 29.96% | 30.73% | Upgrade
|
| Free Cash Flow Margin | 22.69% | 26.31% | 29.84% | 45.75% | 42.59% | 44.06% | Upgrade
|
| EBITDA | 144.09 | 108.32 | 113.89 | 125.96 | 128.73 | 112.31 | Upgrade
|
| EBITDA Margin | 22.92% | 22.46% | 28.34% | 34.42% | 36.38% | 36.64% | Upgrade
|
| D&A For EBITDA | 0.73 | 1.04 | 1.26 | 1.48 | 0.53 | 0.7 | Upgrade
|
| EBIT | 143.36 | 107.28 | 112.63 | 124.48 | 128.2 | 111.61 | Upgrade
|
| EBIT Margin | 22.81% | 22.24% | 28.03% | 34.01% | 36.23% | 36.41% | Upgrade
|
| Effective Tax Rate | 14.74% | 14.79% | 12.71% | 9.99% | 19.45% | 19.28% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.